common themes in hospital dermatology: from morphology ... pda- syllabus common...dermatology from...

Post on 13-Mar-2021

7 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Common  Themes  in  Hospital  Dermatology:    

From  Morphology  to  Management  

Lindy  P.  Fox  MD  Associate  Professor  of  Clinical  Dermatology  Director,    Hospital  Consulta�on  Service  University  of  California,  San  Francisco  

foxli@derm.ucsf.edu  

DISCLOSURE  OF    CONFLICTS  OF  INTEREST  

Lindy  P.  Fox,  MD  

I  have  no  relevant  conflicts  of  interest  to  disclose.  

I  will  be  discussing  off-­‐label  uses  of  medica�ons.    

Goals  of  this  talk  

  Present  common  morphologies  that  arise  during  inpa�ent  consulta�ons  

  Generate  a  working  differen�al  diagnosis  

  Use  cases  to  demonstrate  key  teaching  points  about  diagnosis  or  management  

Morphologies  1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Morbilliform  

  Drug  erup�on    Viral  exanthem    Acute  Gra�  vs.  Host  Disease    Erup�on  of  lymphocyte  recovery    Engra�ment  syndrome    Toxic  erythema  of  chemotherapy      Toxin  mediated  erythema    RARE:  disseminated  histoplasmosis,  cryptococcosis,  coccidioidomycosis  

Acute  GVHD  

  Timing  (average  25d)  – Hyperacute  (within  first  14  d  post  HSCT)  

  Morbilliform  erup�on  – Perifollicular  accentua�on  – Acral  distribu�on  

  Ears,  hands,  periungual  areas  

  Associated  nausea,  vomi�ng,  diarrhea,  hyperbilirubinemia  

Viral  Reac�va�on  and  GVHD  

  HHV6  appears  to  play  a  role  in  poten�a�ng  acute  and  chronic  GVHD  – Associated  with  poorer  outcome    

  CMV    seroposi�vity  in  donor  or  recipient  is  associated  with  cGVHD  

  EBV,  HHV7  may  occur  in  the  post  transplant  se�ng,  but  has  NOT  been  shown  to  be  associated  with  GVHD                      

de Pagter et al Biol Blood Marrow Transplant. 2008; 14:831-9 Zerr et al. Clin Infect Dis 2005; 40: 932-40 Kitamura et al. JAAD. 2008; 58: 802-9

Papules/  Papulonodules  

  Deep  fungal  (o�en  purpuric,  necro�c)    Sep�c  emboli    Sweets  syndrome    Leukemia/lymphoma  cu�s    Kaposis  sarcoma    Cutaneous  metastasis    Sarcoidosis  

Purple  Plumb  

  Lymphoma    Kaposi  Sarcoma    Bacillary  angiomatosis    Melanoma    Cutaneous  metastasis  

Celluli�c  Plaques  

  Celluli�s    Stasis  derma��s    Deep  fungal  infec�on  (especially  Cryptococcus)    Carcinoma  erysipeloides    Neutrophilic  disease  (Sweets,  NEH)    Acute  inflammatory  edema  (ICU)  

Cryptococcal  celluli�s  s/p  liver  transplant  for  HCV  

  Celluli�s-­‐  most  common  presenta�on  in  OTR  

  Bilateral  disease  is  common  

  Look  for  extracutaneous  infec�on  

Palpable  purpura    

  Small  or  mixed  (small  and  medium)  vessel  vasculi�s  

  Secondary  hemorrhage  into  papular  process    Leukemia/lymphoma  cu�s    Sweet’s  syndrome    Cutaneous  reac�on  to  cytarabine  

Intravascular Vascular

Thrombotic Embolic

Re�form  Purpura    DDX  

Re�form  Purpura    Vascular-­‐  infiltra�on  in  vessel  wall    

  Infectious –  Bacterial

  Meningococcemia   Gonococcemia   Staphylococcus   E. coli   Klebsiella   Pseudomonas

–  Fungal   Mucor/ Rhizopus   Aspergillus   Candida   Fusarium

–  Other   Strongyloidiasis   Lucio (leprosy)

  Vasculitis –  IgA vasculitis –  Connective tissue disease

vasculitis –  Mixed cryoglobulinemia –  Microscopic polyangiitis –  Wegener granulomatosis –  Churg-Strauss syndrome –  Polyarteritis nodosa –  Levamisole/cocaine

  Calciphylaxis   Oxalosis

Re�form  Purpura  Thrombo�c  

  Abnormal coagulation   Thrombotic vasculopathy   Platelet Plugging   Cold-related   Red cell occlusion   Phlegmasia   Levamisole/cocaine   Calciphylaxis!!

Re�form  Purpura    Emboli  

  Emboli- DDX –  Cholesterol –  Cardiac

  Marantic endocarditis   Septic endocarditis   Libman-Sachs endocarditis   Atrial myxoma

–  Air –  Fat  

  Clinical –  Few lesions –  Acral/distal –  Cholesterol

  Post procedure –  Air/Fat

  Upper extrem> lower extrem

Concomitant  Thrombosis  and  Vasculi�s  

  Cyroglubulinemia    Sep�c  vasculi�s    Levamisole  exposure  

Sclerodermoid  

  Carcinoma  en  cuirasse    Radia�on  derma��s  (chronic)    GVHD  (chronic)    Nephrogenic  systemic  fibrosis    Scleroderma    Paraffinoma    Lipodermatosclerosis    Scleredema    Scleromyxedema    

Subcutaneous  nodules  

  Sweets  syndrome    Panniculi�s    Deep  fungal  infec�on    Nodular  tuberculid/erythema  induratum    Polyarteri�s  nodosa  

JAAD  2005;  53:S154-­‐6  

cPAN    Papulonodules  on  the  legs  

  Histopathology  -­‐dermohypodermal  junc�on  –  Muscular  walled  artery  

  Evaluate  for  associated  infec�ons/medica�ons  

  Evaluate  for  APLA  

  Treat  with  immunosuppression  –  ?  Role  for  an�coagula�on  

  Papulonodules  on  the  legs  

  Histopathology  -­‐dermohypodermal  junc�on  –  Muscular  walled  artery  OR  vein  

  PPD  or  quan�FERON®  Gold  posi�ve  

  Treat  with  3-­‐4  drug  therapy  

Nodular  Tuberculid  vs.  

Necro�c  papules/plaques    

  Deep  fungal  infec�on    Sep�c  emboli    Pyoderma  gangrenosum    Ecthyma  gangrenosum    Calciphylaxis    Malignant  syphilis    Malignancy  

Calciphylaxis analagous to a “myocardial infarction” occurring in the skin

Vascular stenosis (medial arterial calcification and subintimal thrombosis) develops slowly

+ Thrombosis (acute event)

= Calciphylaxis

(tissue ischemia stellate purpuric plaques)

Weenig. J Am Acad Dermatol 2008;58:458-71

Calciphylaxis = cutaneous “MI” Implications for treatment

  Ca2+, PO4, PTH- sodium thiosulfate, cinacalcet, lanthanum, bisphosphonates, parathyroidectomy, etc   NEED TO ADDRESS THROMBUS- tPA   Warfarin with caution, if at all

  Inhibits activation of matrix G1a protein (Vitamin K dependent protein that inhibits vascular calcification)   Reduced functional protein C levels in ESRD patients with calciphylaxis (normal in ESRD without calciphylaxis)   Cases of warfarin induced calciphylaxis reported

Ulcers    

  Venous  insufficiency  ulcers    Pyoderma  gangrenosum    Deep  fungal  infec�on    Chronic  viral  infec�ons  (HSV,  CMV)  

Vesiculobullous    

  Autoimmune  bullous  disorder    Drug  induced  bullous  disorder  (esp  SJS,  linear  IgA  to  vancomycin)  

  Herpe�c  (HSV  or  VZV,  localized  or  disseminated)    Contact  derma��s      Miliaria  crystallina      Coma  bulla    Edema  bulla  

Drug-Induced Linear IgA Disease�  Common  causes  

–  Vancomycin�–  Penicillins�–  Cephalosporins�–  Captopril�

  Others  –  Amiodarone  –  Sulfamethoxazole    –  Diclofenac  –  Furosemide  –  Glyburide  –  GCSF  –  IFN  –  Lithium  –  Phenytoin  –  Piroxicam  –  Rifampin  

Pustules  

  Bacterial  infec�on      Sep�c  emboli    Acute  generalized  exanthematous  pustulosis    Drug  induced  hypersensi�vity  reac�on    Pustular  psoriasis    Steroid  acne    Folliculi�s-­‐  non-­‐bacterial  (Demodex,  Pityrosporum,  eosinophilic)    Candidiasis-­‐  localized  and  disseminated  

Candidemia  Purpura with pale, sometimes pustular, centers

Image  courtesy  of  Peter  Heald,  MD    

Erythema,  macular  (acute)  

  Toxin  mediated  erythema    Drug  erup�on  (esp  toxic  epidermal  necrolysis,  acute  generalized  exanthematous  pustulosis)  

  GVHD  (acute)    Viral  exanthem    Kawasaki  disease  

Erythroderma,  subacute  to  chronic    

  CTCL    Atopic  derma��s    Drug  erup�on  (Drug  induced  hypersensi�vity)    Psoriasis    Hyperkerato�c  scabies  

Hypersensi�vity  Reac�ons    “DRESS”-­‐  Drug  reac�on  w/  eosinophilia  and  systemic  symptoms    “DIHS”=  Drug  induced  hypersensi�vity  syndrome    Begins  2-­‐  6  weeks  a�er  medica�on  started      Viral  reac�va�on  (esp  HHV6)  appears  to  play  a  real  role  

  Long  term  toxici�es  include:    –  Thyroid-­‐  check  TSH  monthly  for  6  months  –  Cardiac-­‐  low  EF,  give  pa�ents  ER  warnings  

Hypersensi�vity  Reac�ons    Each  class  of  drug  causes  a  slightly  different  clinical  picture    Facial  edema  characteris�c  of  all    An�convulsants:    

–  3  weeks  –  Atypical  lymphocytosis,  hepa�c  failure  

  Dapsone:  –  6  weeks  –  No  eosinophilia  

  Allopurinol:  –  7  weeks  –  Elderly  pa�ent  on  thiazide  diure�c  –  Renal  failure    –  Requires  steroid  sparing  agent  to  treat  (avoid  azathioprine)  

Erythroderma,  erosive    

  Toxic  epidermal  necrolysis      GVHD  (TEN-­‐like)    Linear  IgA  bullous  dermatosis  (drug  induced)    Acute  generalized  exanthematous  pustulosis    Staphylococcal  scalded  skin  syndrome    Toxic  erythema  of  chemotherapy  

Ulcers,  oral  and  genital    

  HSV    CMV    EBV    Aphthae    Post  transplant  lymphoprolifera�ve  disease  (rare)    Sweets  syndrome  (rare)    Malignancy  

Case  

  28  M  with  advanced  HIV    Found  down  in  his  home  with  facial  necrosis  

  4-­‐6  weeks  with  slowly  increasing,  painful  lesion  on  face  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

HHV6  plays  a  role  in  GVHD  and    hypersensi�vity  drug  erup�ons  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

“Purple  Plumb”:    Lymphoma    Kaposi  Sarcoma    Bacillary  angiomatosis    Melanoma    Cutaneous  metastasis  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Celluli�s  is  a  common  presenta�on  of  cryptococcosis  in    the  immunosuppressed  pa�ent  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

The  cutaneous  reac�on  to  cytarabine  may  mimic  vasculi�s  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Levamisole  exposure  classically    presents  with  concomitant  vasculi�s  and  thrombosis  

Inpa�ent  Dermatology  From  Morphologies  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Paraffinomas  may  develop    many  years  a�er  ini�al  exposure  and  may  travel  to  non-­‐injected  areas  

Inpa�ent  Dermatology  From  Morphologies  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Rule  out  TB  before  making  a    defini�ve  diagnosis  of  PAN  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

When  trea�ng  calciphylaxis    address  Ca2+/PO4  and  thrombus  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Chronic  HSV  is  common  in    immunosuppressed,    bedridden  pa�ents  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Drug-­‐induced  linear  IgA  disease    may  be  mucosal  predominant  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Disseminated  candidiasis  presents  as  purpura  with  pale,  pustular  centers  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Eosinophilia  is  a  common  finding    in  toxin  mediated  erythemas  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Watch  for  late  cardiac  involvement    in  pa�ents  with  drug  hypersensi�vity  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

Toxic  erythema  of  chemotherapy    is  a  rare  cause  of  widespread    cutaneous  necrosis  

Inpa�ent  Dermatology  From  Morphology  to  Management  

1.  Morbilliform  2.  Papules/Papulonodules  3.  Celluli�c  plaques  4.  Palpable  purpura    5.  Re�form  Purpura  6.  Sclerodermoid  7.  Subcutaneous  nodules  8.  Necro�c  papules/plaques    9.  Ulcers    10.  Vesiculobullous  11.  Pustules  12.  Erythema,  macular  (acute)  13.  Erythroderma,  subacute  to  chronic    14.  Erythroderma,  erosive    15.  Ulcers,  oral  and  genital    

More  than  one  infec�on  or  e�ology  may    account  for  the  clinical  picture,  especially  in  immunocompromised  pa�ents  

Inpa�ent  Dermatology  Rules  to  Live  By  

  If  more  than  one  morphology  is  present,  work  up  each  one  separately  

  Most  cases  require  some  degree  of  clinicopathologic  correla�on    

  Think  of  the  zebras-­‐  this  is  how  you  will  make  the  rare  diagnosis  

top related